Pharmacokinetics and bioequivalence of a rosuvastatin/ezetimibe fixed-dose combination tablet versus single agents in healthy male subjects - Concepedia

Concepedia

Publication | Closed Access

Pharmacokinetics and bioequivalence of a rosuvastatin/ezetimibe fixed-dose combination tablet versus single agents in healthy male subjects

11

Citations

0

References

2017

Year

Woo Youl Kang, Sook Jin Seong, Boram Ohk, Mi‐Ri Gwon, Bo Kyung Kim, Sookie Na, Hyun-Ju Kim, Young‐Ran Yoon, Hae Won Lee

International Journal of Clinical Pharmacology and Therapeutics

Abstract

The rosuvastatin/ezetimibe (10/10 mg) FDC was bioequivalent to single agents concomitantly administered. A single dose of rosuvastatin/ezetimibe as the FDC or as single agents was well tolerated. .